Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-Current Deffered Revenue (2018 - 2021)

Historic Non-Current Deffered Revenue for TransMedics (TMDX) over the last 4 years, with Q3 2021 value amounting to $1.6 million.

  • TransMedics' Non-Current Deffered Revenue fell 43.13% to $1.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.6 million, marking a year-over-year decrease of 43.13%. This contributed to the annual value of $1.6 million for FY2020, which is 31105.4% up from last year.
  • According to the latest figures from Q3 2021, TransMedics' Non-Current Deffered Revenue is $1.6 million, which was down 43.13% from $1.5 million recorded in Q2 2021.
  • In the past 5 years, TransMedics' Non-Current Deffered Revenue registered a high of $3.4 million during Q4 2018, and its lowest value of $389000.0 during Q4 2019.
  • In the last 4 years, TransMedics' Non-Current Deffered Revenue had a median value of $1.3 million in 2020 and averaged $1.3 million.
  • In the last 5 years, TransMedics' Non-Current Deffered Revenue tumbled by 8850.13% in 2019 and then soared by 31105.4% in 2020.
  • TransMedics' Non-Current Deffered Revenue (Quarter) stood at $3.4 million in 2018, then tumbled by 88.5% to $389000.0 in 2019, then soared by 311.05% to $1.6 million in 2020, then grew by 1.06% to $1.6 million in 2021.
  • Its last three reported values are $1.6 million in Q3 2021, $1.5 million for Q2 2021, and $1.6 million during Q1 2021.